Filing Analysis
Securities Offering
Filed Apr 22, 2026
MEDIUM
Neuraxis, Inc. has amended its At-The-Market (ATM) offering agreement with Craig-Hallum Capital Group LLC to increase the maximum aggregate offering price from $6,270,000 to $11,500,000. The company reported selling 1,125,281 shares under the original agreement between August 2025 and April 2026.
Red Flags
- Significant potential for shareholder dilution as the offering size was nearly doubled.
- Ongoing reliance on equity sales to provide liquidity/capital.
Key Facts
- ATM offering capacity increased by $5,230,000 to a new total of $11,500,000.
- 1,125,281 shares of common stock were sold under the agreement from August 29, 2025, through April 20, 2026.
- The sales agent for the offering is Craig-Hallum Capital Group LLC.
- The offering is conducted under an effective Registration Statement on Form S-3 (File No. 333-283798).
Regulation FD Disclosure
Filed Apr 21, 2026
MEDIUM
Neuraxis, Inc. announced preliminary unaudited financial results for Q1 2026, reporting a 77% increase in net sales to $1.6 million compared to the prior year. The company maintains a strong gross margin of approximately 87.5% but continues to operate at a loss.
Red Flags
- Operating loss of $1.7 million exceeds total quarterly revenue of $1.6 million.
- Based on the $1.7 million quarterly operating loss, the $7.1 million cash balance provides approximately four quarters of runway without additional funding or revenue scaling.
Key Facts
- Preliminary net sales of approximately $1.6 million for the three months ended March 31, 2026, up from $0.9 million in the same period of 2025.
- Cash and cash equivalents were approximately $7.1 million as of March 31, 2026.
- Estimated gross profit of $1.4 million for Q1 2026.
- Estimated operating loss of $1.7 million for the quarter ended March 31, 2026.
- The company is an emerging growth company and is still finalizing its quarter-end financial close process.
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.